Product Information
Name:AVE3085
Controlled Product
Brand:Biosynth
Description:AVE3085 is a novel drug that inhibits the activity of soluble guanylate cyclase. It has been shown to have a positive effect on cardiac hypertrophy and chronic kidney disease (CKD) by inhibiting the production of reactive oxygen species by pde5 inhibitors and organic nitrates. This drug also has an effect on blood pressure in clinical studies, which may be due to its inhibition of polymerase chain reaction. AVE3085 is currently undergoing phase III clinical trials.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:255.29 g/mol
Formula:C16H14FNO
Purity:Min. 95%
Technical inquiry about: AVE3085
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.